e-learning
resources
Berlin 2001
Sunday 23.09.2001
Physiological and disease-related changes in lung cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective role of PARP inhibitors in reperfusion/reoxygenation injury
R. P. Strosznajder, R. Gadomski, G. Czapski, J. Strosznajder (Warsaw, Poland)
Source:
Annual Congress 2001 - Physiological and disease-related changes in lung cells
Session:
Physiological and disease-related changes in lung cells
Session type:
Thematic Poster Session
Number:
560
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. P. Strosznajder, R. Gadomski, G. Czapski, J. Strosznajder (Warsaw, Poland). Protective role of PARP inhibitors in reperfusion/reoxygenation injury. Eur Respir J 2001; 16: Suppl. 31, 560
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Pathology of ILDs
Pathology of pulmonary hypertension
Related content which might interest you:
Role of poly(ADP-ribose) polymerase-1 and its inhibitor in ventilator-induced lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 559s
Year: 2004
Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Differential role of NO synthases in ischemia/reperfusion-induced lung injury
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Protective effects of peroxiredoxin 6 on lipopolysaccharide-induced acute lung injury
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Role of eNOS in ischemia/reperfusion-induced lung injury
Source: Eur Respir J 2007; 30: Suppl. 51, 293s
Year: 2007
sGC activator BAY 412272 attenuates ischemia/reperfusion injury of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
The role of sulfhydryl compounds in the prevention of acute bleomycin-induced lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 487s
Year: 2002
Protective effect of a phosphodiesterase 4 and 5 inhibitor on pulmonary damages induced by microcystin-LR
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007
Protective effects of peroxiredoxin 6 on ventilation-induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin
Source: Eur Respir J 2008; 31: 363-371
Year: 2008
Plant Kunitz proteinase inhibitor attenuates inflammation, oxidative stress and remodeling induced by elastase in mice
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Protective effect of Polydexyribonucleotide against lipopolysaccharide-induced acute lung injury in rats
Source: International Congress 2017 – From respiratory muscles to acute respiratory failure
Year: 2017
Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats
Source: Eur Respir J 2009; 33: 398-404
Year: 2009
Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Lack of poly(ADP-ribose) polymerase-1 does not affect acute lung injury but induces excessive lung remodelling after hyperoxia exposure
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005
Combined inhibition of NADPH oxidase and inducible NOS in prevention of ischemia/reperfusion injury of the lung
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept